Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,041 public trials 566 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

NCT01804140

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Sedona, Arizona, United States
  • Tucson, Arizona, United States
  • Burbank, California, United States
  • Rancho Cucamonga, California, United States
View all 20 locations
View Trial Details
Completed

Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma

NCT02011113

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Celgene Trial Site Nagoya, Aichi-ken, Japan
  • Celgene Trial Site Kamogawa, Chiba, Japan
  • Celgene Trial Site Fukuoka, Japan
  • Celgene Trial Site Hiroshima, Japan
View all 14 locations
View Trial Details
Completed

Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients

NCT02471820

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • General Hospital of Athens "G. Gennimatas" Athens, Attica, Greece
  • General Hospital of Athens "Alexandra" Athens, Attica, Greece
  • University General Hospital of Patras Pátrai, Patra, Greece
  • Theageneio Anticancer Hospital of Thessaloniki Thessaloniki, Greece
View Trial Details

Related conditions